2010 annual financial data
Celldex Therapeutics 2010 Operating cash flow margin
Direct answer
Operating cash flow margin was -64.91%.
Operating income was -6,455,000 USD and net income was -2,533,000 USD.
Operating cash flow was -30,372,000 USD.
Get free Celldex Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 46,793,000 USD
- Operating income
- -6,455,000 USD
- Net income
- -2,533,000 USD
- Operating cash flow
- -30,372,000 USD